Showing results (91-100 of 220) with videos related to
Sort By:
Pageof 22
British Journal of Clinical Pharmacology|October 21, 2005
Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipientsC Dansirikul, S B Duffull, R G Morris, et al.BMC Health Services Research|November 8, 2015
Actions following adverse drug events - how do these influence uptake and utilisation of newer and/or similar medications?Nadia Barozzi, G M E E Geeske Peeters, Susan E TettGenome Research|February 8, 2017
Microbial strain-level population structure and genetic diversity from metagenomesDuy Tin Truong, Adrian Tett, Edoardo Pasolli, et al.Clinical Pharmacokinetics|May 4, 2016
Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?Emily Brooks, Susan E Tett, Nicole M Isbel, et al.Clinical Pharmacology and Therapeutics|December 24, 2002
Population pharmacokinetics of tacrolimus in adult kidney transplant recipientsChristine E Staatz, Charlene Willis, Paul J Taylor, et al.Therapeutic Drug Monitoring|January 22, 2002
Population pharmacokinetics of lamotrigineV Chan, R G Morris, K F Ilett, et al.The Journal of Rheumatology|October 11, 2002
Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexateSamantha J Carmichael, Joanne Beal, Richard O Day, et al.British Journal of Clinical Pharmacology|August 5, 2003
Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetilB Shum, S B Duffull, P J Taylor, et al.Journal of Human Hypertension|May 24, 2003
Using a problem detection study (PDS) to identify and compare health care provider and consumer views of antihypertensive therapyA H Wade, D N Weir, A P Cameron, et al.The Journal of Rheumatology|May 1, 1995
Adverse drug reactions and their measurement in the rheumatic diseasesR O Day, D I Quinn, P G Conaghan, et al.Pageof 22